1. Diabetes mellitus and metformin in hepatocellular carcinoma
    Koji Fujita et al, 2016, World Journal of Gastroenterology CrossRef
  2. Metformin attenuates hypoxia‑induced resistance to cisplatin in the HepG2 cell line
    Hiromasa Fujita et al, 2018, Oncology Letters CrossRef
  3. Expression of AXL receptor tyrosine kinase relates to monocyte dysfunction and severity of cirrhosis
    Robert Brenig et al, 2020, Life Science Alliance CrossRef
  4. Metformin exerts anti-cancerogenic effects and reverses epithelial-to-mesenchymal transition trait in primary human intrahepatic cholangiocarcinoma cells
    Sabina Di Matteo et al, 2021, Scientific Reports CrossRef
  5. Coexpression of EphA10 and Gli3 promotes breast cancer cell proliferation, invasion and migration
    Jing Peng et al, 2021, Journal of Investigative Medicine CrossRef
  6. TAM Receptors in the Pathophysiology of Liver Disease
    Emilio Flint et al, 2022, Livers CrossRef
  7. Metformin potentiates the anticancer activities of gemcitabine and cisplatin against cholangiocarcinoma cells in vitro and in vivo
    Hua-Qiang Zhu et al, 2016, Oncology Reports CrossRef
  8. Metformin-suppressed differentiation of human visceral preadipocytes: Involvement of microRNAs
    Koji Fujita et al, 2016, International Journal of Molecular Medicine CrossRef
  9. Association of Diabetes Mellitus and Cholangiocarcinoma: Update of Evidence and the Effects of Antidiabetic Medication
    Charupong Saengboonmee et al, 2021, Canadian Journal of Diabetes CrossRef
  10. Metformin Use and Survival in Patients with Advanced Extrahepatic Cholangiocarcinoma: A Single-Center Cohort Study in Fuyang, China
    Jinqing Wu et al, 2021, Gastroenterology Research and Practice CrossRef
  11. Inhibitory effect of metformin combined with gemcitabine on pancreatic cancer cells in vitro and in vivo
    Yuqi Shi et al, 2016, Molecular Medicine Reports CrossRef
  12. Targeting c-Met and AXL Crosstalk for the Treatment of Hepatocellular Carcinoma
    Yeliz Yılmaz et al, 2021, Liver Cancer in the Middle East CrossRef
  13. Metformin Treatment Suppresses Melanoma Cell Growth and Motility Through Modulation of microRNA Expression
    Hui-Wen Tseng et al, 2019, Cancers CrossRef
  14. Repurposing metformin for the treatment of gastrointestinal cancer
    Ademar Dantas Cunha Júnior et al, 2021, World Journal of Gastroenterology CrossRef
  15. Metformin Induces Growth Inhibition and Cell Cycle Arrest by Upregulating MicroRNA34a in Renal Cancer Cells
    Wei Xie et al, 2017, Medical Science Monitor CrossRef
  16. Combined transcriptome and metabolome analyses of metformin effects reveal novel links between metabolic networks in steroidogenic systems
    Sameer S. Udhane et al, 2017, Scientific Reports CrossRef
  17. Anti-diabetic drug metformin inhibits cell proliferation and tumor growth in gallbladder cancer via G0/G1 cell cycle arrest
    Takuma Yamashita et al, 2020, Anti-Cancer Drugs CrossRef
  18. How metformin affects various malignancies by means of microRNAs: a brief review
    Nahid Alimoradi et al, 2021, Cancer Cell International CrossRef
  19. HNRNPA2/B1 is upregulated in endocrine-resistant LCC9 breast cancer cells and alters the miRNA transcriptome when overexpressed in MCF-7 cells
    Carolyn M. Klinge et al, 2019, Scientific Reports CrossRef
  20. miR-10a-5p Inhibits the Differentiation of Goat Intramuscular Preadipocytes by Targeting KLF8 in Goats
    Qing Xu et al, 2021, Frontiers in Molecular Biosciences CrossRef
  21. Anticancer mechanisms of metformin: A review of the current evidence
    Bin Zhao et al, 2020, Life Sciences CrossRef
  22. Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis
    Xiaowen Huang et al, 2020, EBioMedicine CrossRef
  23. Metformin‑induced apoptosis facilitates degradation of the cellular caspase 8 (FLICE)‑like inhibitory protein through a caspase‑dependent pathway in human renal cell carcinoma A498 cells
    Ji‑Hoon Jang et al, 2018, Oncology Letters CrossRef
  24. Crucial microRNAs and genes in metformin’s anti-pancreatic cancer effect explored by microRNA-mRNA integrated analysis
    Yilong Li et al, 2018, Investigational New Drugs CrossRef